PubMed HealthSearch

PubMed · 31433

Potentiation of neostigmine and pyridostigmine by 4-aminopyridine in the rat.

Abstract

The interaction between 4-aminopyridine and neostigmine or pyridostigmine was studied in vivo in the rat sciatic nerve-anterior tibialis preparation using the constant infusion of pancuronium technique. The ED50 (dose of drug which produced a 50% antagonism) of neostigmine, pyridostigmine and 4-aminopyridine were 18, 49 and 440 microgram kg(-1) respectively. The addition of 100 microgram kg(-1) of 4-aminopyridine, which produced no antagonism by itself, decreased the neostigmine ED50 to 7.4 microgram kg(-1). The addition of 200 microgram kg(-1) of 4-aminopyridine, which produced a 30% antagonism by itself, decreased the ED50 of pyridostigmine to 11 microgram kg(-1). We conclude that both neostigmine and pyridostigmine interact with 4-aminopyrine synergistically.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R D Miller, P A Dennissen, F van der Pol, S Agoston, L H Booij, J F Crul. 1978. Potentiation of neostigmine and pyridostigmine by 4-aminopyridine in the rat.. https://doi.org/10.1111/j.2042-7158.1978.tb13368.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Inhibitory effect of kanamycin on evoked transmitter release. Reversal by 3,4-diaminopyridine.

The effect of kanamycin (Kn) on evoked transmitter release was examined in frog end-plates in vitro. By a presynaptic action, Kn (0.02 to 1 mM) significantly reduced the amount of acetylcholine liberated by nerve stimulation. In addition to its presynaptic effects, Kn (0.96 mM) decreased the size of the miniature end-plate potentials possibly by acting at the postsynaptic level. 3,4-Diaminopyridine (4.5 microM) reversed the presynaptic effects of Kn but did not modify its postsynaptic action.

Aminopyridines